Kyverna Therapeutics, Inc. (KYTX) Earnings
|
Expand Research on KYTX
| Next EPS Date | 11/18/26 | EPS Growth Rate | -36.5% |
|---|---|---|---|
| Average EPS % Beat Rate | +24.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +3.8% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/18/26  |
Q326 | N/A | -$1.16 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/11/26 |
Q226 | -$0.63 | -$1.08 | +$0.45 | N/A | N/A | N/A |  | | Details | |
| 5/12/26 |
Q126 | -$0.66 | -$1.04 | +$0.38 | N/A | N/A | N/A | | | Details | |
| 4/1/26 |
Q126 | N/A | -$1.01 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/13/25 |
Q325 | -$0.85 | -$1.02 | +$0.17 | N/A | N/A | N/A | | | Details | |
| 8/12/25 |
Q225 | -$0.97 | -$1.02 | +$0.05 | N/A | N/A | N/A | | | Details | |
| 5/14/25 |
Q125 | -$1.03 | N/A | N/A | N/A | N/A | N/A | | | Details | |
| 3/27/25 |
Q125 | N/A | -$0.95 | N/A | N/A | N/A | N/A | N/A | N/A |
